Annual Drug Patent Expirations for EXSERVAN
Exservan is a drug marketed by Aquestive and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
Drug patent litigation for EXSERVAN.
This drug has one hundred and fifty-seven patent family members in nineteen countries.
The generic ingredient in EXSERVAN is riluzole. One supplier is listed for this compound. Additional details are available on the riluzole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
